Benkowitz Michael's Form 4 filing
United Therapeutics Corp (UTHR) · filed Jan 7, 2026
- Accession no.
- 0001673232-26-000003
- Filed
- Jan 7, 2026
- Trade date
- Jan 5, 2026
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 15 non-derivative transactions and 1 derivative transaction. Open-market sales total $3.84M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Benkowitz MichaelCIK 0001673232 | Officer (PRESIDENT AND COO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 5, 2026 | Common Stock | MOption exerciseAcquired | +7,875 | $146.03 | +$1,149,986.25 | 7,875 | Indirect | |
| Jan 5, 2026 | Common Stock | SSaleDisposed | −376 | $480.68 | −$180,735.68 | 7,499 | Indirect | |
| Jan 5, 2026 | Common Stock | SSaleDisposed | −891 | $481.86 | −$429,337.26 | 6,608 | Indirect | |
| Jan 5, 2026 | Common Stock | SSaleDisposed | −471 | $482.72 | −$227,361.12 | 6,137 | Indirect | |
| Jan 5, 2026 | Common Stock | SSaleDisposed | −375 | $483.80 | −$181,425 | 5,762 | Indirect | |
| Jan 5, 2026 | Common Stock | SSaleDisposed | −629 | $484.99 | −$305,058.71 | 5,133 | Indirect | |
| Jan 5, 2026 | Common Stock | SSaleDisposed | −899 | $486.05 | −$436,958.95 | 4,234 | Indirect | |
| Jan 5, 2026 | Common Stock | SSaleDisposed | −461 | $487.40 | −$224,691.4 | 3,773 | Indirect | |
| Jan 5, 2026 | Common Stock | SSaleDisposed | −641 | $488.38 | −$313,051.58 | 3,132 | Indirect | |
| Jan 5, 2026 | Common Stock | SSaleDisposed | −364 | $489.49 | −$178,174.36 | 2,768 | Indirect | |
| Jan 5, 2026 | Common Stock | SSaleDisposed | −893 | $490.11 | −$437,668.23 | 1,875 | Indirect | |
| Jan 5, 2026 | Common Stock | SSaleDisposed | −647 | $491.35 | −$317,903.45 | 1,228 | Indirect | |
| Jan 5, 2026 | Common Stock | SSaleDisposed | −598 | $492.44 | −$294,479.12 | 630 | Indirect | |
| Jan 5, 2026 | Common Stock | SSaleDisposed | −201 | $493.47 | −$99,187.47 | 429 | Indirect | |
| Jan 5, 2026 | Common Stock | SSaleDisposed | −429 | $494.27 | −$212,041.83 | 0 | Indirect |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 5, 2026 | Common Stock | MOption exerciseDisposed | −7,875 | $0.00 | $0 | 52,315 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.